LanZhou Foci Pharmaceutical Co.,Ltd. (002644.SZ)
CNY 7.25
(-0.82%)
CNY 7.25
(-0.82%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 83.27 Million CNY | -40.26% |
| 2022 | 139.4 Million CNY | 24.06% |
| 2021 | 112.36 Million CNY | 74.39% |
| 2020 | 64.43 Million CNY | -17.65% |
| 2019 | 78.24 Million CNY | -9.17% |
| 2018 | 86.14 Million CNY | 1.09% |
| 2017 | 85.21 Million CNY | 31.75% |
| 2016 | 64.68 Million CNY | 55.97% |
| 2015 | 41.47 Million CNY | 45.84% |
| 2014 | 28.43 Million CNY | 8.36% |
| 2013 | 26.24 Million CNY | -4.93% |
| 2012 | 27.6 Million CNY | -12.46% |
| 2011 | 31.53 Million CNY | -0.42% |
| 2010 | 31.66 Million CNY | 16.98% |
| 2009 | 27.06 Million CNY | 8.49% |
| 2008 | 24.94 Million CNY | -9.95% |
| 2007 | 27.7 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 12.59 Million CNY | -45.24% |
| 2024 Q3 | 4.06 Million CNY | -67.76% |
| 2024 Q1 | 22.99 Million CNY | 186.49% |
| 2023 Q4 | 8.02 Million CNY | 52.6% |
| 2023 FY | 83.27 Million CNY | -40.26% |
| 2023 Q3 | 5.26 Million CNY | -85.52% |
| 2023 Q1 | 33.65 Million CNY | -54.11% |
| 2023 Q2 | 36.32 Million CNY | 7.94% |
| 2022 Q4 | 73.34 Million CNY | 2622.79% |
| 2022 Q3 | 2.69 Million CNY | -89.93% |
| 2022 FY | 139.4 Million CNY | 24.06% |
| 2022 Q2 | 26.75 Million CNY | 4.56% |
| 2022 Q1 | 25.58 Million CNY | -12.12% |
| 2021 Q2 | 25.89 Million CNY | -6.48% |
| 2021 Q4 | 29.11 Million CNY | -1.87% |
| 2021 FY | 112.36 Million CNY | 74.39% |
| 2021 Q1 | 27.68 Million CNY | 895.98% |
| 2021 Q3 | 29.67 Million CNY | 14.6% |
| 2020 Q3 | 12.11 Million CNY | -87.85% |
| 2020 Q1 | 15.78 Million CNY | 314.89% |
| 2020 FY | 64.43 Million CNY | -17.65% |
| 2020 Q4 | 2.77 Million CNY | -77.05% |
| 2020 Q2 | 99.65 Million CNY | 531.21% |
| 2019 Q2 | 36.9 Million CNY | 141.58% |
| 2019 Q4 | -7.34 Million CNY | -121.99% |
| 2019 FY | 78.24 Million CNY | -9.17% |
| 2019 Q1 | 15.27 Million CNY | -19.67% |
| 2019 Q3 | 33.41 Million CNY | -9.46% |
| 2018 Q2 | 23.53 Million CNY | -10.36% |
| 2018 FY | 86.14 Million CNY | 1.09% |
| 2018 Q4 | 19.01 Million CNY | 9.74% |
| 2018 Q3 | 17.32 Million CNY | -26.38% |
| 2018 Q1 | 26.26 Million CNY | 10.51% |
| 2017 FY | 85.21 Million CNY | 31.75% |
| 2017 Q3 | 20.27 Million CNY | -19.44% |
| 2017 Q4 | 23.76 Million CNY | 17.2% |
| 2017 Q2 | 25.16 Million CNY | 57.2% |
| 2017 Q1 | 16 Million CNY | 44.67% |
| 2016 Q4 | 11.06 Million CNY | -41.56% |
| 2016 Q1 | 11.35 Million CNY | 69.52% |
| 2016 Q2 | 23.32 Million CNY | 105.34% |
| 2016 FY | 64.68 Million CNY | 55.97% |
| 2016 Q3 | 18.93 Million CNY | -18.81% |
| 2015 Q4 | 6.69 Million CNY | -55.32% |
| 2015 Q3 | 14.99 Million CNY | 7.74% |
| 2015 Q2 | 13.91 Million CNY | 137.55% |
| 2015 Q1 | 5.85 Million CNY | 38.7% |
| 2015 FY | 41.47 Million CNY | 45.84% |
| 2014 Q4 | 4.22 Million CNY | -69.17% |
| 2014 Q3 | 13.69 Million CNY | 46.75% |
| 2014 Q2 | 9.33 Million CNY | 693.0% |
| 2014 Q1 | 1.17 Million CNY | 277.3% |
| 2014 FY | 28.43 Million CNY | 8.36% |
| 2013 Q3 | 11.59 Million CNY | 20.01% |
| 2013 Q1 | 5.64 Million CNY | -23.79% |
| 2013 Q4 | -663.95 Thousand CNY | -105.73% |
| 2013 FY | 26.24 Million CNY | -4.93% |
| 2013 Q2 | 9.66 Million CNY | 71.19% |
| 2012 Q1 | 5.3 Million CNY | 5.41% |
| 2012 Q2 | 6.86 Million CNY | 29.57% |
| 2012 Q3 | 8.02 Million CNY | 16.82% |
| 2012 FY | 27.6 Million CNY | -12.46% |
| 2012 Q4 | 7.4 Million CNY | -7.69% |
| 2011 FY | 31.53 Million CNY | -0.42% |
| 2011 Q4 | 5.02 Million CNY | -55.11% |
| 2011 Q3 | 11.2 Million CNY | 18.84% |
| 2011 Q2 | 9.42 Million CNY | 60.57% |
| 2011 Q1 | 5.87 Million CNY | -18.29% |
| 2010 Q3 | 9.99 Million CNY | 0.0% |
| 2010 Q4 | 7.18 Million CNY | -28.14% |
| 2010 FY | 31.66 Million CNY | 16.98% |
| 2009 FY | 27.06 Million CNY | 8.49% |
| 2008 FY | 24.94 Million CNY | -9.95% |
| 2007 FY | 27.7 Million CNY | 0.0% |